These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9758471)

  • 21. Case 28-1999: Creutzfeldt-Jakob disease.
    Zeidler M; Green AJ; Zerr I
    N Engl J Med; 2000 Jan; 342(4):292-3. PubMed ID: 10660389
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical algorithm for cerebrospinal fluid test of 14-3-3 protein in diagnosis of Creutzfeldt-Jacob disease].
    Lemstra AW; van Meegen M; Baas F; van Gool WA
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1467-71. PubMed ID: 11503317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease.
    Geschwind MD; Martindale J; Miller D; DeArmond SJ; Uyehara-Lock J; Gaskin D; Kramer JH; Barbaro NM; Miller BL
    Arch Neurol; 2003 Jun; 60(6):813-6. PubMed ID: 12810484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
    Van Everbroeck B; Boons J; Cras P
    Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid 14-3-3 protein: variability of sporadic Creutzfeldt-Jakob disease, laboratory standards, and quantitation.
    Aksamit AJ
    Arch Neurol; 2003 Jun; 60(6):803-4. PubMed ID: 12810481
    [No Abstract]   [Full Text] [Related]  

  • 26. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.
    Sanchez-Juan P; Green A; Ladogana A; Cuadrado-Corrales N; Sáanchez-Valle R; Mitrováa E; Stoeck K; Sklaviadis T; Kulczycki J; Hess K; Bodemer M; Slivarichová D; Saiz A; Calero M; Ingrosso L; Knight R; Janssens AC; van Duijn CM; Zerr I
    Neurology; 2006 Aug; 67(4):637-43. PubMed ID: 16924018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study.
    Otto M; Wiltfang J; Schütz E; Zerr I; Otto A; Pfahlberg A; Gefeller O; Uhr M; Giese A; Weber T; Kretzschmar HA; Poser S
    BMJ; 1998 Feb; 316(7131):577-82. PubMed ID: 9518907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of Creutzfeldt-Jakob disease. Routine tonsil biopsy for diagnosis of new variant Creutzfeldt-Jakob disease is not justified.
    Zeidler M; Knight R; Stewart G; Ironside JW; Will RG; Green AJ; Pocchiari M
    BMJ; 1999 Feb; 318(7182):538. PubMed ID: 10024280
    [No Abstract]   [Full Text] [Related]  

  • 29. Cerebrospinal-fluid test for new-variant Creutzfeldt-Jakob disease.
    Will RG; Zeidler M; Brown P; Harrington M; Lee KH; Kenney KL
    Lancet; 1996 Oct; 348(9032):955. PubMed ID: 8843819
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular diagnostic tools in Creutzfeldt-Jakob disease and other prion disorders.
    Van Everbroeck B; Boons J; De Leenheir E; Lübke U; Cras P
    Expert Rev Mol Diagn; 2004 May; 4(3):351-9. PubMed ID: 15137902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of human S100 protein and preparation of specific antiserum for S100 and establishment of a quantitative measurement for S100 protein in CSF specimens of patients with Creutzfeldt Jakob disease].
    Zhang F; Zhang J; Zhou W; Dong X; Hung T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):305-8. PubMed ID: 12665890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic usefulness of the determination of protein 14-3-3 in cerebrospinal fluid in Creutzfeld-Jakob disease].
    Sáiz A; Marín C; Tolosa E; Graus F
    Neurologia; 1998; 13(7):324-8. PubMed ID: 9810794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implications of CJD data need to be clear before release.
    Thornett A
    BMJ; 2000 Sep; 321(7262):701. PubMed ID: 11202929
    [No Abstract]   [Full Text] [Related]  

  • 34. Early identification of variant Creutzfeldt-Jakob disease.
    Pocchiari M
    BMJ; 1998 Feb; 316(7131):563-4. PubMed ID: 9518890
    [No Abstract]   [Full Text] [Related]  

  • 35. [Current topics of prion disease].
    Furukawa H; Doh-ura K
    Uirusu; 2001 Dec; 51(2):151-8. PubMed ID: 11977755
    [No Abstract]   [Full Text] [Related]  

  • 36. Antemortem diagnosis of variant Creutzfeldt-Jakob disease.
    Petersen RB
    Lancet; 1999 Jan; 353(9148):163-4. PubMed ID: 9923866
    [No Abstract]   [Full Text] [Related]  

  • 37. Unsuccessful intraventricular pentosan polysulphate treatment of variant Creutzfeldt-Jakob disease.
    Whittle IR; Knight RS; Will RG
    Acta Neurochir (Wien); 2006 Jun; 148(6):677-9; discussion 679. PubMed ID: 16598408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New variant Creutzfeldt-Jakob disease.
    Gordon N
    Int J Clin Pract; 1999 Sep; 53(6):456-9. PubMed ID: 10622074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease.
    Noguchi-Shinohara M; Hamaguchi T; Kitamoto T; Sato T; Nakamura Y; Mizusawa H; Yamada M
    Neurology; 2007 Jul; 69(4):360-7. PubMed ID: 17646628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Creutzfeldt-Jakob disease: diagnosis, incidence, prevention and treatment].
    Croes EA; van Gool WA; Jansen GH; van Duijn CM
    Ned Tijdschr Geneeskd; 2002 Apr; 146(16):750-4. PubMed ID: 11998351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.